Cargando…

CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility

BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyfarth, Julia, Ahlert, Heinz, Rosenbauer, Joachim, Baechle, Christina, Roden, Michael, Holl, Reinhard W., Mayatepek, Ertan, Meissner, Thomas, Jacobsen, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801137/
https://www.ncbi.nlm.nih.gov/pubmed/29411179
http://dx.doi.org/10.1186/s40348-018-0080-7
_version_ 1783298294751952896
author Seyfarth, Julia
Ahlert, Heinz
Rosenbauer, Joachim
Baechle, Christina
Roden, Michael
Holl, Reinhard W.
Mayatepek, Ertan
Meissner, Thomas
Jacobsen, Marc
author_facet Seyfarth, Julia
Ahlert, Heinz
Rosenbauer, Joachim
Baechle, Christina
Roden, Michael
Holl, Reinhard W.
Mayatepek, Ertan
Meissner, Thomas
Jacobsen, Marc
author_sort Seyfarth, Julia
collection PubMed
description BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibitor. Previous studies identified association of CISH promoter region single nucleotide polymorphisms (SNPs) with susceptibility to infectious diseases. METHODS: Here we analyzed allele frequencies of three CISH SNPs (i.e., rs809451, rs414171, rs2239751) in a study of T1D patients (n = 260, onset age < 5 years, duration > 10 years). Minor allele frequencies were compared to a control cohort of the 1000 Genomes Project. Assigned haplotypes were determined for effects on T1D manifestation and severity. Finally, the CISH haplotype influence on cytokine signaling and function was explored in T cells from healthy donors. RESULTS: We detected similar minor allele frequencies between T1D patients and the control cohort. T1D onset age, residual serum C-peptide level, and insulin requirement were comparable between different haplotypes. Only minor differences between the haplotypes were found for in vitro cytokine (i.e., IL-2, IL-7)-induced CIS mRNA expression. STAT5 phosphorylation was induced by IL-2 or IL-7, but no differences were found between the haplotypes. T(REG) purified from healthy donors with the two most common haplotypes showed similar capacity to inhibit heterologous effector T cells. CONCLUSIONS: This study provides no evidence for an association of CISH promoter SNPs with susceptibility to T1D or severity of disease. In contrast to previous studies, no influence of different haplotypes on CIS mRNA expression or T cell-mediated functions was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40348-018-0080-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5801137
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58011372018-02-13 CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility Seyfarth, Julia Ahlert, Heinz Rosenbauer, Joachim Baechle, Christina Roden, Michael Holl, Reinhard W. Mayatepek, Ertan Meissner, Thomas Jacobsen, Marc Mol Cell Pediatr Research BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibitor. Previous studies identified association of CISH promoter region single nucleotide polymorphisms (SNPs) with susceptibility to infectious diseases. METHODS: Here we analyzed allele frequencies of three CISH SNPs (i.e., rs809451, rs414171, rs2239751) in a study of T1D patients (n = 260, onset age < 5 years, duration > 10 years). Minor allele frequencies were compared to a control cohort of the 1000 Genomes Project. Assigned haplotypes were determined for effects on T1D manifestation and severity. Finally, the CISH haplotype influence on cytokine signaling and function was explored in T cells from healthy donors. RESULTS: We detected similar minor allele frequencies between T1D patients and the control cohort. T1D onset age, residual serum C-peptide level, and insulin requirement were comparable between different haplotypes. Only minor differences between the haplotypes were found for in vitro cytokine (i.e., IL-2, IL-7)-induced CIS mRNA expression. STAT5 phosphorylation was induced by IL-2 or IL-7, but no differences were found between the haplotypes. T(REG) purified from healthy donors with the two most common haplotypes showed similar capacity to inhibit heterologous effector T cells. CONCLUSIONS: This study provides no evidence for an association of CISH promoter SNPs with susceptibility to T1D or severity of disease. In contrast to previous studies, no influence of different haplotypes on CIS mRNA expression or T cell-mediated functions was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40348-018-0080-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-02-06 /pmc/articles/PMC5801137/ /pubmed/29411179 http://dx.doi.org/10.1186/s40348-018-0080-7 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Seyfarth, Julia
Ahlert, Heinz
Rosenbauer, Joachim
Baechle, Christina
Roden, Michael
Holl, Reinhard W.
Mayatepek, Ertan
Meissner, Thomas
Jacobsen, Marc
CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title_full CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title_fullStr CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title_full_unstemmed CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title_short CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
title_sort cish promoter polymorphism effects on t cell cytokine receptor signaling and type 1 diabetes susceptibility
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801137/
https://www.ncbi.nlm.nih.gov/pubmed/29411179
http://dx.doi.org/10.1186/s40348-018-0080-7
work_keys_str_mv AT seyfarthjulia cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT ahlertheinz cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT rosenbauerjoachim cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT baechlechristina cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT rodenmichael cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT hollreinhardw cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT mayatepekertan cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT meissnerthomas cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility
AT jacobsenmarc cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility